No Data
HC Wainwright & Co. Reiterates Buy on Summit Therapeutics, Maintains $44 Price Target
Summit Therapeutics Analyst Ratings
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Merck to Buy Rights to Chinese Cancer Drug for up to $3.3B
Belite Bio Analyst Ratings
Scholar Rock Holding Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.